- Home
- COGT vs TWO Comparison
COGT vs TWO Comparison
Compare COGT & TWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- TWO
- Stock Information
- Founded
- COGT 2014
- TWO 2009
- Country
- COGT United States
- TWO United States
- Employees
- COGT N/A
- TWO N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- TWO Real Estate Investment Trusts
- Sector
- COGT Health Care
- TWO Real Estate
- Exchange
- COGT Nasdaq
- TWO Nasdaq
- Market Cap
- COGT 1.1B
- TWO 1.1B
- IPO Year
- COGT 2018
- TWO 2009
- Fundamental
- Price
- COGT $13.05
- TWO $10.36
- Analyst Decision
- COGT Strong Buy
- TWO Buy
- Analyst Count
- COGT 11
- TWO 8
- Target Price
- COGT $21.20
- TWO $12.50
- AVG Volume (30 Days)
- COGT 1.2M
- TWO 1.9M
- Earning Date
- COGT 08-05-2025
- TWO 10-27-2025
- Dividend Yield
- COGT N/A
- TWO 15.06%
- EPS Growth
- COGT N/A
- TWO N/A
- EPS
- COGT N/A
- TWO N/A
- Revenue
- COGT N/A
- TWO $257,735,000.00
- Revenue This Year
- COGT N/A
- TWO N/A
- Revenue Next Year
- COGT N/A
- TWO N/A
- P/E Ratio
- COGT N/A
- TWO N/A
- Revenue Growth
- COGT N/A
- TWO N/A
- 52 Week Low
- COGT $3.72
- TWO $9.50
- 52 Week High
- COGT $13.50
- TWO $14.28
- Technical
- Relative Strength Index (RSI)
- COGT 66.38
- TWO 58.51
- Support Level
- COGT $11.87
- TWO $9.79
- Resistance Level
- COGT $13.50
- TWO $10.01
- Average True Range (ATR)
- COGT 0.55
- TWO 0.20
- MACD
- COGT 0.05
- TWO 0.07
- Stochastic Oscillator
- COGT 77.16
- TWO 79.67
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
About TWO Two Harbors Investment Corp
Two Harbors Investment Corp is a real estate investment trust focused on investing in, financing, and managing residential mortgage-backed securities, or RMBS; residential mortgage loans; mortgage servicing rights; and commercial real estate. The majority of the company's investment portfolio is split between agency RMBS purchased from government-sponsored enterprises and nonagency RMBS. Two Harbors derives nearly all of its revenue in the form of interest income collected from its investments. The majority of this income is generated by available-for-sale securities, while residential mortgage loans held for investment in securitization trusts also contribute a sizable amount.